CARDALIS DIN 02542102
Health Canada record
| Active ingredient(s) | BENAZEPRIL HYDROCHLORIDE 2.5 MG; SPIRONOLACTONE 20 MG |
|---|---|
| Dosage form | Tablet (Chewable) |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 16-Dec-2024 |
| Current status date | 16-Dec-2024 |
| Source | Health Canada DPD |
Establishment licence of the holder
Ceva Animal Health Inc — licence 102054, currently licensed, last inspection rating C (2024-07-31).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing BENAZEPRIL HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02290340 | BENAZEPRIL | AA PHARMA INC | Tablet | BENAZEPRIL HYDROCHLORIDE 10 MG | Marketed |
| 02273918 | BENAZEPRIL | AA PHARMA INC | Tablet | BENAZEPRIL HYDROCHLORIDE 20 MG | Marketed |
| 02290332 | BENAZEPRIL | AA PHARMA INC | Tablet | BENAZEPRIL HYDROCHLORIDE 5 MG | Marketed |
| 02542080 | CARDALIS | CEVA ANIMAL HEALTH INC | Tablet (Chewable) | BENAZEPRIL HYDROCHLORIDE 5 MG; SPIRONOLACTONE 40 MG | Marketed |
| 02542099 | CARDALIS | CEVA ANIMAL HEALTH INC | Tablet (Chewable) | BENAZEPRIL HYDROCHLORIDE 10 MG; SPIRONOLACTONE 80 MG | Approved |
| 02220555 | FORTEKOR FLAVOR TABS | ELANCO CANADA LIMITED | Tablet | BENAZEPRIL HYDROCHLORIDE 20 MG | Marketed |
| 02305232 | FORTEKOR FLAVOR TABS | ELANCO CANADA LIMITED | Tablet | BENAZEPRIL HYDROCHLORIDE 2.5 MG | Marketed |
| 02220563 | FORTEKOR FLAVOR TABS | ELANCO CANADA LIMITED | Tablet | BENAZEPRIL HYDROCHLORIDE 5 MG | Marketed |
| 00885843 | LOTENSIN 10MG | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | BENAZEPRIL HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 00885851 | LOTENSIN 20MG | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | BENAZEPRIL HYDROCHLORIDE 20 MG | Cancelled Post Market |
| 00885835 | LOTENSIN 5MG | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | BENAZEPRIL HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 02231551 | PMS-BENAZEPRIL | PHARMASCIENCE INC | Tablet | BENAZEPRIL HYDROCHLORIDE 20 MG | Cancelled Pre Market |
| 02231550 | PMS-BENAZEPRIL | PHARMASCIENCE INC | Tablet | BENAZEPRIL HYDROCHLORIDE 10 MG | Cancelled Pre Market |
| 02231548 | PMS-BENAZEPRIL | PHARMASCIENCE INC | Tablet | BENAZEPRIL HYDROCHLORIDE 5 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 31812 | 2023-10-11 | New Drug Submission (NDS) |
International API supply for BENAZEPRIL HYDROCHLORIDE
7 valid EDQM Certificates of Suitability from 7 holders. 14 active FDA Drug Master Files.
Request a quote for CARDALIS